Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophrenia

PSD95: A synaptic protein implicated in schizophrenia or autism?

(2018) Austin A. Coley et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

PV Interneurons: Critical Regulators of E/I Balance for Prefrontal Cortex-Dependent Behavior and Psychiatric Disorders

(2018) Brielle R. Ferguson et al.   Frontiers in Neural Circuits

Optogenetic induction of the schizophrenia-related endophenotype of ventral hippocampal hyperactivity causes rodent correlates of positive and cognitive symptoms

(2018) Amy R. Wolff et al.   Scientific Reports

Schizophrenia-related cognitive dysfunction in the Cyclin-D2 knockout mouse model of ventral hippocampal hyperactivity

(2018) Christina M. Grimm et al.   Translational Psychiatry

A Multilevel Functional Study of aSNAP25At-Risk Variant for Bipolar Disorder and Schizophrenia

(2017) Josselin Houenou et al.   JOURNAL OF NEUROSCIENCE

GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia

(2017) R Tao et al.   MOLECULAR PSYCHIATRY

NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update

(2017) Daniela Cadinu et al.   NEUROPHARMACOLOGY

Markedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia

(2016) Brad R. Rocco et al.   BIOLOGICAL PSYCHIATRY

Modelling the cognitive and neuropathological features of schizophrenia with phencyclidineAbdul-MonimZNeillJCReynoldsGP (2007) Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J Psychopharmacol21:198–205.

(2016) Gavin P Reynolds et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Prenatal phencyclidine treatment induces behavioral deficits through impairment of GABAergic interneurons in the prefrontal cortex

(2016) Kazuya Toriumi et al.   PSYCHOPHARMACOLOGY

Olanzapine Prevents the PCP-induced Reduction in the Neurite Outgrowth of Prefrontal Cortical Neurons via NRG1

(2016) Qingsheng Zhang et al.   Scientific Reports

Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents

(2015) Ben Grayson et al.   BEHAVIOURAL BRAIN RESEARCH

SNAP25 Is Associated With Schizophrenia and Major Depressive Disorder in the Han Chinese Population

(2015) Qingzhong Wang et al.   JOURNAL OF CLINICAL PSYCHIATRY

Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice

(2015) Lakshmi Rajagopal et al.   PSYCHOPHARMACOLOGY

The involvement of distraction in memory deficits induced by NMDAR antagonism: Relevance to cognitive deficits in schizophrenia

(2014) Ben Grayson et al.   BEHAVIOURAL BRAIN RESEARCH

Functions of gamma-band synchronization in cognition: from single circuits to functional diversity across cortical and subcortical systems

(2014) Conrado A. Bosman et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Unmet Needs in the Treatment of Schizophrenia

(2014) Leslie Citrome   JOURNAL OF CLINICAL PSYCHIATRY

Policy: NIH to balance sex in cell and animal studies

(2014) Janine A. Clayton et al.   NATURE

Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: A translational link to humans

(2013) Joanna C. Neill et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver

(2013) Scott A. Schobel et al.   NEURON

Schizophrenia Is a Cognitive Illness

(2013) René S. Kahn et al.   JAMA Psychiatry

Neonatal administration of phencyclidine decreases the number of putative inhibitory interneurons and increases neural excitability to auditory paired clicks in the hippocampal CA3 region of freely moving adult mice

(2012) M. Okamoto et al.   NEUROSCIENCE

The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats

(2012) M. Horiguchi et al.   PSYCHOPHARMACOLOGY

Negative and Nonemotional Interference with Visual Working Memory in Schizophrenia

(2011) Alan Anticevic et al.   BIOLOGICAL PSYCHIATRY

A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior

(2011) M Carlén et al.   MOLECULAR PSYCHIATRY

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism

(2010) Joanna C. Neill et al.   PHARMACOLOGY & THERAPEUTICS

Paradoxical False Memory for Objects After Brain Damage

(2010) S. M. McTighe et al.   SCIENCE

Evidence that putative ADHD low risk alleles atSNAP25may increase the risk of schizophrenia

(2009) L.S. Carroll et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Neonatal Phencyclidine Treatment in Mice Induces Behavioral, Histological and Neurochemical Abnormalities in Adulthood

(2009) Akiko Nakatani-Pawlak et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Attenuation of Phencyclidine-Induced Object Recognition Deficits by the Combination of Atypical Antipsychotic Drugs and Pimavanserin (ACP 103), a 5-Hydroxytryptamine2A Receptor Inverse Agonist

(2009) S. Snigdha et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

(2009) Juan E Belforte et al.   NATURE NEUROSCIENCE

Review of Pathological Hallmarks of Schizophrenia: Comparison of Genetic Models With Patients and Nongenetic Models

(2009) Hanna Jaaro-Peled et al.   SCHIZOPHRENIA BULLETIN

Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors

(2008) Taku Nagai et al.   PSYCHOPHARMACOLOGY

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

(2008) John E. Lisman et al.   TRENDS IN NEUROSCIENCES

Phencyclidine-Induced Cognitive Deficits in Mice Are Improved by Subsequent Subchronic Administration of the Novel Selective α7 Nicotinic Receptor Agonist SSR180711

(2007) Kenji Hashimoto et al.   BIOLOGICAL PSYCHIATRY

Differential regulation of the NMDA receptor by acute and sub-chronic phencyclidine administration in the developing rat

(2007) Noelle C. Anastasio et al.   JOURNAL OF NEUROCHEMISTRY